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CAK-handed kinase activation
A protein kinase that activates cyclin-dependent kinases has been
identified as a related catalytic subunit in association with a novel
cyclin regulatory subunit - it is itself a cyclin-dependent kinase.
Progression through the eukaryotic cell cycle is con-
trolled by the sequential formation, activation and in-
activation of a series of protein serine/threonine kinases,
the cyclin-dependent kinases (CDKs). Each CDK is
thought to phosphorylate specific substrates and to coor-
dinate the changes that occur during a particular transi-
tion in the cell cycle. Because of their central role, a great
deal of effort has been devoted to understanding the reg-
ulation of CDKs and several mechanisms have been iden-
tified. Availability of their essential cyclin subunits is
restricted to the appropriate period in the cycle by con-
trol of cyclin synthesis and degradation. In addition, sev-
eral CDK-cyclin complexes are inhibited by the binding
of small protein inhibitors, the abundance of which is
also tightly controlled. Furthermore, the activities of
CDKs are regulated post-translationally by reversible
phosphorylation of their catalytic subunits (Fig. 1).
Regulation by phosphorylation is best understood for the
archetypal CDK-cyclin complex formed between a
B-type cyclin and CDK1, usually called Cdc2 after the
gene that encodes its homologue in the fission yeast,
Schizosaccharomyces pombe. The Cdc2-cyclin B kinase
complex forms MPF (first purified as a 'maturation-pro-
moting factor' from Xenopus oocytes) and induces the
events of metaphase in all eukaryotes that have been
studied. Phosphorylation of Cdc2 at sites near to its
active site - tyrosine 15 and, in vertebrates, threonine
14 - inhibits the activity of the kinase complex. The
enzymes that regulate the phosphorylation state of these
Fig. 1. Activation of Cdc2-cyclin B protein kinase (MPF). As cyclin B is synthesized during S and G2 phases of the cell cycle, it associates
with Cdc2. Active CDK-activating kinase (CAK) phosphorylates Cdc2 at threonine 161, stabilizing its association with cyclin B, but the
complex is not immediately active because the Cdc2 subunit is phosphorylated by other kinases at inhibitory sites, threonine 14 and
tyrosine 15. Final activation of MPF occurs when these sites are dephosphorylated by CDC25 phosphatase. This step is inhibited by a
type-2A protein phosphatase but stimulated by MPF as part of a positive feedback mechanism. Active MPF induces the cell to enter
metaphase. MPF is switched off when cyclin B is degraded and threonine 161 dephosphorylated. Other CDKs may be activated more
rapidly, without being subject to phosphorylation at inhibitory sites. CAK consists of a catalytic subunit related to Cdc2 (MO1 5/CDK7)
along with a cyclin, cyclin H; an activating phosphorylation at threonine 176 of the MO1 5/CDK7 subunit is required for activity. The
role of phosphorylation at an additional site, serine 170, is unknown. Distinct, unidentified kinases may be responsible for phosphorylat-
ing residues of M01 5/CDK7. The protein phosphatases that act on these sites and on threonine 161 of Cdc2 are unknown.
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sites are themselves acutely controlled and responsive to
intracellular signals that delay entry into mitosis if, for
example, DNA replication has not been successfully
completed. Conversely, phosphorylation at an additional
site, threonine 161, which is in a region known as the
T loop of the kinase's structure, is essential for the activ-
ity of the Cdc2-cyclin B complex [1]. This site is con-
served in other CDKs, and they all seem to be
phosphorylated in a similar manner. Indeed, many other
protein kinases have activating phosphorylation sites in
the corresponding region [2] (Fig. 2).
Phosphorylation at threonine 161 is induced when a
newly synthesized cyclin B molecule associates with
Cdc2, possibly because cyclin binding induces a confor-
mational change in the catalytic subunit. The phospho-
rylation is catalyzed by a distinct kinase activity, called
CAK, for CDK-activating kinase [3]. Recently, this
kinase has been purified by several research teams, and its
catalytic subunit shown to be the product of the M015
gene [4-6], which was originally isolated from a Xenopus
cDNA library in a search for genes encoding kinase cat-
alytic subunits related to Cdc2 [7]. This discovery imme-
diately suggested a number of intriguing possibilities
about the mechanism of activation of CAK itself- as its
catalytic subunit is related to Cdc2, could its activity be
controlled in similar ways?
As purified, CAK contains other polypeptides besides
MO15. One of these has been identified by Fisher and
Morgan [8] as a novel member of the cyclin family,
cyclin H. Independently, Makela et al. [9] isolated cyclin
H using the 'two-hybrid' screen, which relies on co-
expression of genes in yeast, to look for proteins that
interact with MO15. Formation of an active kinase
requires the association of cyclin H with MO15, and can
be reconstituted in vitro using recombinant proteins,
demonstrating that CAK is itself a cyclin-dependent
kinase [8,9]. This makes MO15 the seventh member of
the family to be confirmed as being dependent on a
cyclin for activity, so it is now dubbed CDK7 (CDKs are
being sequentially numbered as they are identified,
whereas cyclins receive a letter). Furthermore, for CAK
to be active requires phosphorylation of M015/CDK7
in the T loop region at threonine 176 (Fig. 2); there is
also phosphorylation at serine 170, although it is not
clear what role this phosphorylation might have, as it is
dispensable for kinase activity [8,10,11]. Threonine 176
phosphorylation in MO15/CDK7 complexes may be
catalyzed by yet another kinase that acts 'upstream' of
CAK, although it is also possible that it results from an
autophosphorylation reaction [8].
So does the activity of CAK change during the cell
cycle? Like other CDKs, the M015/CDK7 catalytic
subunit is present throughout the cycle. Although we do
not yet know whether the amount of cyclin H changes,
the kinase seems to be constitutively active during the
cell cycle [11-14]. The amount of MO15/CDK7
decreases in cells when they leave the cell cycle and
Fig. 2. Amino-acid sequences of the T-loop region of CDKs
and the corresponding regions of some other protein kinases
for which phosphorylation sites have been determined [2].
The kinases are: Cdc2; CDK2; CDK4; M015/CDK7; a mitogen-
activated protein kinase (MAPK), p40mapk; a MAP kinase
kinase (MKK); and cAMP-dependent protein kinase (PKA).
Phosphorylated residues are highlighted in blue.
become quiescent, but this seems to be the case for a
number of other CDKs and cyclins, including substrates
of CAK [11,12]. But there are a number of possible
reasons why changes in activity might have been over-
looked. The association of regulatory molecules, or
changes in phosphorylation, could be lost when the
complex is diluted in buffers prior to assay in vitro.
Alternatively, CAK may be constitutively active, but its
ability to phosphorylate CDKs controlled through
other proteins binding to the substrate, or by modulation
of a protein phosphatase (as yet unidentified) that opposes
the actions of CAK. Phosphorylation of threonine 161
in Cdc2 is not readily reversed once a stable complex
between Cdc2 and cyclin B has formed, but there
could be an initial, transient phase, during which an
okadaic-acid-sensitive phosphatase may compete with
CAK (Fig. 1) [15].
It is also possible that a similar phosphatase negatively
regulates formation of active CAK itself, and this phos-
phatase might be down-regulated upon entry into mito-
sis. One observation of potential interest here is that the
rate of activation of recombinant MO 15/CDK7 added to
cell-free extracts of Xenopus eggs is greater in a mitotic
extract than in an interphase one [11]. Nevertheless, in
such extracts, Cdc2 seems to get phosphorylated rapidly
when cyclin B binds [3], and the major control over the
timing of activation of the Cdc2-cyclin B protein
kinase is through the inhibitory phosphorylation sites,
threonine 14 and tyrosine 15.
In somatic cells, there might be levels of control that do
not occur in Xenopus egg extracts: for instance, the sub-
cellular distribution of the enzyme could be altered. In
such cells, M015/CDK7 is predominantly nuclear, as it
is in Xenopus oocytes, which contain a large nucleus, the
germinal vesicle [7,10,12-14]. MO15/CDK7 has a clas-
sical nuclear localization sequence within its primary
structure that is required for direction to the nucleus and
formation with cyclin H of an active CAK complex
[10,14]. Some of the CDKs that are potential substrates
of CAK are also found in the nucleus, although it is not
clear how a nuclear CAK could act upon Cdc2-cyclin B
complexes, which are thought to be phosphorylated in
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the cytoplasm. This dilemma highlights the sparse and
sometimes conflicting information that we have con-
cerning nuclear-cytoplasmic communication during
CDK activation - perhaps the process is highly dy-
namic, with kinases and phosphatases shuttling in and out
of the nucleus [12].
Even if there are no dramatic changes in the ability of
CAK to influence the timing of CDK activation, could
phosphorylation at threonine 161 in Cdc2 (and the cor-
responding sites in other CDKs) play a more subtle role
in the process? Phosphorylation stabilizes the association
of the CDK catalytic subunit with cyclin, and the site
becomes resistant to dephosphorylation once the com-
plex has formed [10,15,16]. This may ensure that the
kinase complex remains stable and active until after it
has completed its function, when progression to the
next phase of the cell cycle is warranted. Cyclin degra-
dation is then triggered. In the absence of cyclin, threo-
nine 161 is no longer a substrate for CAK [3] and the
site becomes exposed again to phosphatase action,
returning Cdc2 to its inactive, interphase state [17] (Fig.
1). In other words, the process of CDK activation has
directionality. Other controls may impinge upon the
activity of a CDK to arrest cell-cycle progression, but.
there is no going back to the state of the previous cell-
cycle phase.
Of course, a number of additional points are raised by the
latest results. There are some hints that putative regula-
tory subunits other than cyclin H may be found in puri-
fied complexes [8,10,12] - these may give specificity of
activity towards different substrates, or may be subject to
different controls. And although MO15/CDK7 com-
plexed to cyclin H has been shown to be capable of
phosphorylating CDK2 [5], CDK4 [18] and an unclassi-
fied CDK from Caenorhabditis [4], there may be addi-
tional homologues of MO15 with preference for
particular substrates. No dramatic changes in CAK activ-
ity across the normal cell cycle have been found, but
phosphorylation in the T loop of CDKs could be
responsive to signals that alter the progression of the cell
cycle under adverse conditions.
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